Huadong Deferred Long Term Liab from 2010 to 2024
| 000963 Stock | 36.10 0.09 0.25% |
Deferred Long Term Liabilities | First Reported 2018-06-30 | Previous Quarter 709.8 M | Current Value 804.7 M | Quarterly Volatility 228.4 M |
Check Huadong Medicine financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Huadong Medicine's main balance sheet or income statement drivers, such as Interest Expense of 120.7 M, Selling General Administrative of 2.8 B or Total Revenue of 42.7 B, as well as many indicators such as . Huadong financial statements analysis is a perfect complement when working with Huadong Medicine Valuation or Volatility modules.
Huadong | Deferred Long Term Liab |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Huadong Stock
Huadong Medicine financial ratios help investors to determine whether Huadong Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Huadong with respect to the benefits of owning Huadong Medicine security.